View Single Post
Old 04-18-2012, 08:45 AM   #4
jjames
Junior Member
 
Join Date: Apr 2012
Posts: 3
Re: NCCN Guidelines and adjuvant therapy

I was not tested for the KI 67. I think I am getting a clearer picture of the benefits - it seems to cut the recurrance rate in half? What I'm maybe not understanding are the long-term risks. I guess we can put up with anything if its temporary and think it will save our lives,thus a few months of chemo and a year of herceptin.
I'm wondering what the long-term side effects are of both chemo and herceptin - when in reality I may be over-treating myself.
I have read the studies on the benefits of treatment for early stage her2 cancers, but the medical reasons for not having treatment is "risk and toxcities" and im having a hard time finding more information on that part.

I am 46 and grade 3 so for those reasons one oncologies wants to give me adjunctive therapy for the 6mm tumor.

Scary thought going from a stage 1 to a stage IV and thinking of all those cells that potentially could have seperated. But dont the "clear margins" mean something in that regard?

Thanks for your support!
jjames is offline   Reply With Quote